Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Nutriband Inc. stock logo
NTRB
Nutriband
$8.11
+24.8%
$5.62
$3.72
$11.78
$90.46M1.1880,308 shs753,314 shs
Nevro Corp. stock logo
NVRO
Nevro
$5.85
+0.1%
$5.85
$3.17
$10.37
$224.32M0.81771,452 shs753,602 shs
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
$26.24
+0.2%
$30.56
$5.17
$39.50
$224.51M1.2532,428 shs63,082 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$9.01
-1.4%
$9.30
$8.15
$22.40
$250.90M2.16140,345 shs131,691 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Nutriband Inc. stock logo
NTRB
Nutriband
0.00%+13.50%-2.35%-9.59%+14.13%
Nevro Corp. stock logo
NVRO
Nevro
0.00%0.00%0.00%+1.94%-37.48%
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
0.00%-7.53%-14.56%+2,639,999,900.00%+2,639,999,900.00%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%+10.63%-2.14%-32.05%-44.98%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Nutriband Inc. stock logo
NTRB
Nutriband
2.2779 of 5 stars
3.52.00.00.02.51.70.6
Nevro Corp. stock logo
NVRO
Nevro
0.1984 of 5 stars
1.00.00.00.00.61.70.6
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/AN/AN/AN/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
2.4559 of 5 stars
3.33.00.00.02.61.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Nutriband Inc. stock logo
NTRB
Nutriband
3.00
Buy$13.0062.20% Upside
Nevro Corp. stock logo
NVRO
Nevro
1.92
Reduce$5.36-8.29% Downside
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
0.00
N/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
2.67
Moderate Buy$16.3381.38% Upside

Current Analyst Ratings Breakdown

Latest NTRB, SNWV, ZIMV, and NVRO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00
4/10/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$16.00
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
3/13/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Nutriband Inc. stock logo
NTRB
Nutriband
$2.14M41.78N/AN/A$0.73 per share10.98
Nevro Corp. stock logo
NVRO
Nevro
$408.52M0.55N/AN/A$8.10 per share0.72
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
$36.19M6.17N/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
$443.55M0.57$3.25 per share2.77$15.43 per share0.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Nutriband Inc. stock logo
NTRB
Nutriband
-$5.49M-$0.99N/AN/AN/A-338.51%-54.49%-48.52%N/A
Nevro Corp. stock logo
NVRO
Nevro
-$92.21M-$3.05N/AN/AN/A-16.54%-23.52%-10.83%8/4/2025 (Estimated)
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/A-$4.56N/AN/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
-$393.28M-$0.71N/AN/A-77.31%2.90%1.17%8/7/2025 (Estimated)

Latest NTRB, SNWV, ZIMV, and NVRO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/30/2025Q1 2026
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.13-$0.12+$0.01-$0.12$0.71 million$0.67 million
5/9/2025Q1 2025
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/A-$0.66N/A-$0.66N/A$9.34 million
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
4/28/2025Q4 2025
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.12-$0.18-$0.06-$0.51$0.71 million$0.64 million
3/4/2025Q4 2024
Nevro Corp. stock logo
NVRO
Nevro
-$0.79-$0.64+$0.15-$1.41$102.61 million$105.55 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Nutriband Inc. stock logo
NTRB
Nutriband
N/AN/AN/AN/AN/A
Nevro Corp. stock logo
NVRO
Nevro
N/AN/AN/AN/AN/A
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Nutriband Inc. stock logo
NTRB
Nutriband
0.01
4.96
4.83
Nevro Corp. stock logo
NVRO
Nevro
0.67
5.02
3.76
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
N/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
0.57
1.94
1.38

Institutional Ownership

CompanyInstitutional Ownership
Nutriband Inc. stock logo
NTRB
Nutriband
19.70%
Nevro Corp. stock logo
NVRO
Nevro
95.52%
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
42.53%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Nutriband Inc. stock logo
NTRB
Nutriband
54.09%
Nevro Corp. stock logo
NVRO
Nevro
3.20%
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
36.60%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Nutriband Inc. stock logo
NTRB
Nutriband
1011.15 million5.10 millionNot Optionable
Nevro Corp. stock logo
NVRO
Nevro
1,09038.37 million36.27 millionOptionable
SANUWAVE Health, Inc. stock logo
SNWV
SANUWAVE Health
408.56 millionN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
2,70027.85 million26.77 millionOptionable

Recent News About These Companies

Q1 2025 ZimVie Inc Earnings Call
ZimVie announces launch of its Immediate Molar Implant system in US
ZimVie launches molar implant system
Needham Remains a Hold on ZimVie Inc (ZIMV)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Nutriband stock logo

Nutriband NASDAQ:NTRB

$8.11 +1.61 (+24.77%)
Closing price 04:00 PM Eastern
Extended Trading
$8.13 +0.02 (+0.30%)
As of 04:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Nevro stock logo

Nevro NYSE:NVRO

$5.85 +0.01 (+0.10%)
Closing price 04/2/2025
Extended Trading
$5.85 0.00 (0.00%)
As of 04/2/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

SANUWAVE Health stock logo

SANUWAVE Health NASDAQ:SNWV

$26.24 +0.04 (+0.15%)
As of 04:00 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$9.01 -0.13 (-1.42%)
Closing price 04:00 PM Eastern
Extended Trading
$9.02 +0.01 (+0.06%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.